Peregrine Pharmaceuticals shares owned by Vanguard Group
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $27M | 3.8M | 7.14 |
| 2024-03-31 | $25M | 3.7M | 6.70 |
| 2023-12-31 | $24M | 3.6M | 6.50 |
| 2023-09-30 | $42M | 4.4M | 9.44 |
| 2023-06-30 | $62M | 4.4M | 13.97 |
| 2023-03-31 | $82M | 4.4M | 18.76 |
| 2022-12-31 | $60M | 4.3M | 13.77 |
| 2022-06-30 | $60M | 3.9M | 15.26 |
| 2022-03-31 | $84M | 4.1M | 20.37 |
| 2021-09-30 | $69M | 3.2M | 21.57 |
| 2021-06-30 | $80M | 3.1M | 25.65 |
| 2021-03-31 | $52M | 2.9M | 18.23 |
| 2020-12-31 | $32M | 2.8M | 11.54 |
| 2020-09-30 | $20M | 2.7M | 7.62 |
| 2020-06-30 | $18M | 2.7M | 6.56 |
| 2020-03-31 | $14M | 2.6M | 5.11 |
| 2019-12-31 | $20M | 2.6M | 7.67 |
| 2019-09-30 | $14M | 2.7M | 5.30 |
| 2019-03-31 | $11M | 2.7M | 4.25 |
| 2018-12-31 | $10M | 2.4M | 4.10 |
| 2018-09-30 | $16M | 2.3M | 6.86 |
| 2018-06-30 | $8.7M | 2.2M | 3.92 |
| 2018-03-31 | $5.6M | 2.0M | 2.88 |